Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132874) titled 'An Open-Label, Single-Arm Exploratory Study of Peifeikang in Patients With Major Depressive Disorder' on Sept. 19.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Beijing Anding Hospital, Capital Medical University

Condition: major depressive disorder (MDD)

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-09-23

Target Sample Size: Intervention Group:10;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=341380

Published by HT Digital Content Services with permission from Health Daily Digest....